Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt

Mon, 03rd Jul 2023 10:48

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Yourgene Health PLC, more than doubled to 0.47 pence from 0.20p at Friday's market close, 12-month range 0.12p-8.00p. Shares in the medical diagnostics company rocket as it agrees to a takeover offer from Novacyt SA at 0.522 pence per share in cash. The deal values Yourgene's equity at GBP16.7 million. The companies say the acquisition "strongly aligns" with Novacyt's post-Covid strategy, which included pursuing strategic mergers and acquisitions to support its long-term growth and prioritised the twin objectives of geographic expansion and portfolio development. Shares in Novacyt, a fellow AIM listing, jump 24%.

----------

Verici Dx PLC, up 11% at 13.0p, 12-month range 4.53p-19p. The Cardiff, Wales-based developer of clinical diagnostics for organ transplants receives successful results from its clinical study of Clarava that demonstrate it as a test capable of informing a clear, actionable response from clinicians. Clarava is the company's pre-transplant prognostic test to allow measurement of a patient's immune response to assess the risk of early kidney graft rejection, which could assist an estimated 65,000 patients. Verici Dx says it is on track to launch Clarava commercially in the US before the end of 2023.

----------

AIM - LOSERS

----------

Zanaga Iron Ore Co Ltd, down 22% at 9.75p, 12-month range 1.7p-18.9p. The iron explorer focused on the Republic of the Congo enters into an equity subscription agreement with institutional investor Shard Merchant Capital Ltd. Zanaga will issue up to 36 million shares in up to three tranches of 12 million each. At the current price, the shares will be worth GBP3.7 million in total. Also on Monday, Zanaga reports it swung to a pretax profit in 2022 of USD8.1 million from a loss of USD1.9 million the year before. It generated no revenue, unchanged from a year prior, but reports a USD9.1 million gain on the revaluation of investment.

----------

Kibo Energy PLC, down 12% at 0.05p, 12-month range 0.05p-0.22p. The energy projects in Africa and UK says all funding activities, including the company's proposed AIM-listed vehicle Ultimate Sustainable Energy, have been placed on hold due to delays as a result of "difficulties" at its extraordinary general meeting. Early last month, Kibo reported that five of a total of eight resolutions failed to reach the minimum threshold of 75% of the vote at an EGM. These include equity securities allotment, amendment of the Memorandum of Association and amendment of the Articles of Association. It said back then that 35% of shareholders voted against these resolutions. On Thursday last week, Kibo said it sought funding to address a liquidity crunch. It said liquidity constraints resulted from the "significant" capital required to develop its projects.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
11 Mar 2021 21:12

IN BRIEF: Yourgene Health partners with Cytox to run Alzheimer's test

IN BRIEF: Yourgene Health partners with Cytox to run Alzheimer's test

Read more
1 Mar 2021 15:34

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

Read more
22 Feb 2021 14:31

IN BRIEF: Yourgene, Newcastle Premier Health To Supply Covid Tests

IN BRIEF: Yourgene, Newcastle Premier Health To Supply Covid Tests

Read more
8 Feb 2021 11:56

TRADING UPDATES: Yourgene Full-Year Revenue Warning; UP Global Upbeat

TRADING UPDATES: Yourgene Full-Year Revenue Warning; UP Global Upbeat

Read more
8 Feb 2021 09:13

Yourgene H2 revenues grow less than expected

(Sharecast News) - Molecular diagnostics group Yourgene Health said on Monday that while some strong second-half momentum was expected to deliver double-digit annual growth, the improvement was now seen printing below prior expectations.

Read more
13 Jan 2021 11:50

IN BRIEF: Yourgene Welcomes Screening Recommendation In Belgium

IN BRIEF: Yourgene Welcomes Screening Recommendation In Belgium

Read more
11 Jan 2021 13:57

IN BRIEF: New Covid-19 Variant No Problem For Yourgene Clarigene Assay

IN BRIEF: New Covid-19 Variant No Problem For Yourgene Clarigene Assay

Read more
24 Dec 2020 09:49

Yourgene gets approval for 'Test to Release' Covid-19 scheme

(Sharecast News) - Molecular diagnostics company Yourgene Health announced on Thursday that Yourgene Genomic Services had been added to the UK government's approved Covid-19 private testing providers list for the 'Test to Release for International Travel' scheme introduced on 15 December, and also for general coronavirus testing.

Read more
24 Dec 2020 09:14

Yourgene Health Enters UK's List Of Approved Virus Testing Providers

Yourgene Health Enters UK's List Of Approved Virus Testing Providers

Read more
24 Dec 2020 07:40

LONDON MARKET PRE-OPEN: Network International Responds To Short Seller

LONDON MARKET PRE-OPEN: Network International Responds To Short Seller

Read more
17 Dec 2020 16:30

UK EARNINGS SUMMARY: GRC International Interim Loss Narrows

UK EARNINGS SUMMARY: GRC International Interim Loss Narrows

Read more
2 Dec 2020 19:50

UK TRADING UPDATE SUMMARY: Renalytix Teams With US Kidney Foundation

UK TRADING UPDATE SUMMARY: Renalytix Teams With US Kidney Foundation

Read more
2 Dec 2020 09:55

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Read more
3 Nov 2020 15:57

UK TRADING UPDATE SUMMARY: Creo Makes Up To EUR5 Million Acquisition

UK TRADING UPDATE SUMMARY: Creo Makes Up To EUR5 Million Acquisition

Read more
26 Oct 2020 12:00

Yourgene Health First Half Revenue Up Despite International Challenges

Yourgene Health First Half Revenue Up Despite International Challenges

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.